0001076167-11-000018.txt : 20110819
0001076167-11-000018.hdr.sgml : 20110819
20110819092205
ACCESSION NUMBER: 0001076167-11-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110809
FILED AS OF DATE: 20110819
DATE AS OF CHANGE: 20110819
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADOLOR CORP
CENTRAL INDEX KEY: 0001076167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 311429198
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
MAIL ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maurer George R
CENTRAL INDEX KEY: 0001453079
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30039
FILM NUMBER: 111046151
MAIL ADDRESS:
STREET 1: 700 PENNSYLVANIA DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-08-09
0
0001076167
ADOLOR CORP
ADLR
0001453079
Maurer George R
700 PENNSYLVANIA DRIVE
EXTON
PA
19341
0
1
0
0
SVP, Mfg. & Pharm Technologies
Common Stock
2011-08-09
4
A
0
13750
0
A
161025
D
Represents vesting of performance-based deferred share award upon successful completion of a Phase 2 study of ADL5945 in opioid-induced constipation, pursuant to the terms of a performance-based deferred stock agreement with the Company dated September 9, 2010.
/s/ George R. Maurer
2011-08-19